Goldman Sachs Group Inc Cytokinetics Inc Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,184,789 shares of CYTK stock, worth $57.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,184,789

Previous 1,138,154 4.1%

Holding current value

$57.9 Million

Previous $61.7 Million 1.44%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $2.39 Million - $2.81 Million	46,635 Added 4.1%	1,184,789 $62.6 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $21.4 Million - $33.5 Million	446,705 Added 64.6%	1,138,154 $61.7 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $7.9 Million - $13.4 Million	-123,995 Reduced 15.21%	691,449 $48.5 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $2.85 Million - $8.85 Million	105,994 Added 14.94%	815,444 $68.1 Million
Q3 2023 May 14, 2024	SELL	$29.46 - $36.61 $3.12 Million - $3.88 Million	-105,994 Reduced 13.0%	709,450 $20.9 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $11.7 Million - $14.5 Million	-396,788 Reduced 35.87%	709,450 $20.9 Million
Q2 2023 May 14, 2024	BUY	$32.62 - $40.75 $1.03 Million - $1.29 Million	31,714 Added 2.95%	1,106,238 $36.1 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1.03 Million - $1.29 Million	31,714 Added 2.95%	1,106,238 $36.1 Million
Q1 2023 May 14, 2024	BUY	$33.36 - $45.71 $5.48 Million - $7.51 Million	164,273 Added 18.05%	1,074,524 $37.8 Million
Q1 2023 May 11, 2023	BUY	$33.36 - $45.71 $5.48 Million - $7.51 Million	164,273 Added 18.05%	1,074,524 $37.8 Million
Q4 2022 May 14, 2024	BUY	$35.77 - $51.11 $8.3 Million - $11.9 Million	232,167 Added 34.24%	910,251 $41.7 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $8.3 Million - $11.9 Million	232,167 Added 34.24%	910,251 $41.7 Million
Q3 2022 May 14, 2024	BUY	$38.54 - $54.52 $7.99 Million - $11.3 Million	207,331 Added 44.04%	678,084 $32.9 Million
Q3 2022 Nov 10, 2022	BUY	$38.54 - $54.52 $7.99 Million - $11.3 Million	207,331 Added 44.04%	678,084 $32.9 Million
Q2 2022 May 14, 2024	SELL	$33.93 - $48.92 $11.7 Million - $16.9 Million	-344,691 Reduced 42.27%	470,753 $18.5 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $6.47 Million - $9.33 Million	-190,693 Reduced 28.83%	470,753 $18.5 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $3.06 Million - $4.73 Million	102,742 Added 18.39%	661,446 $24.3 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $14.6 Million - $19.7 Million	-425,761 Reduced 43.25%	558,704 $25.5 Million
Q3 2021 Nov 10, 2021	BUY	$18.54 - $35.74 $18.3 Million - $35.2 Million	984,465 New	984,465 $35.2 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Cytokinetics Inc Transaction History